Ebola outbreak in the DRC declared a Public Health Emergency of International Concern
WHO Director-General Dr. Tedros Adhanom Ghebreyesus declared the Ebola virus disease (EVD) outbreak in the Democratic Republic of the Congo (DRC) a Public Health Emergency of International Concern (PHEIC).
The declaration followed a meeting of the International Health Regulations Emergency Committee for EVD in the DRC.... read more
Homeopath fined for prescribing modern medicine injection
The family of a woman in Nagpur who died in 2000 after a homoeopath prescribed her Baralgan and Dexamethasone that caused fatal anaphylaxis was declared as a case of medical negligence by the NCDRC. A state commission had earlier found the same, even though the homoeopath was acquitted in a criminal prosecution over the woman's death.... read more
Greater urgency needed in fight against HIV/AIDS, warns UN agency
The UN program leading the global effort to end AIDS is calling for greater urgency and more funding in the fight against the disease, with data showing that the pace of progress in reducing new HIV infections is slowing, and some countries experiencing a rising number of cases.
The news comes in a new UNAIDS report, Communities at the centre, launched on Tuesday at a community event in Eshowe, South Africa,... read more
Working 9 to 5 May Protect Women From Memory Loss
Working women experience a slower rate of age-related memory loss than their nonworking counterparts, suggests new research.
Results of a large longitudinal study show that memory decline later in life occurred twice as quickly in women who did not work in mid-life compared with those who did.... read more
No Fracture Risk for New Diabetes Drugs in Real-World Study
Sodium-glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes are not associated with an increased fracture risk, new results from a large population-based database suggest.
Researchers studied 73,178 patients aged 40 years and older in the UKCPRD who initiated a glucose-lowering drug starting in 2013. Of those, 9454 patients took an SGLT2 inhibitor (1288 canagliflozin, 5539 dapagliflozin, and 2133 empagliflozin,... read more